College student Clay Scherb, once paralyzed from the neck down after a diving accident, is walking again thanks to a groundbreaking clinical trial at Chicago’s Shirley Ryan AbilityLab. ⁠ ⁠ After qualifying for the study of experimental drug NVG-291, Clay saw dramatic improvements in just nine weeks—going from needing a harness to walking with minimal support.⁠ ⁠ Tap the 🔗 in our bio for more⁠ ⁠ #spinalcordinjury #uiuc #paralyze #newtreatment⁠